Detecting minimal residual disease in neuroblastoma patients-the present state of the art
- 13 June 2005
- journal article
- review article
- Published by Elsevier in Cancer Letters
- Vol. 228 (1-2) , 229-240
- https://doi.org/10.1016/j.canlet.2005.02.053
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Bone marrow trephine biopsy in infantsArchives of Disease in Childhood, 1997
- Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.Journal of Clinical Oncology, 1993
- International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma.Journal of Clinical Oncology, 1988
- Histology of neuroblastoma involving bone marrow: the problem of detecting residual tumour after initiation of chemotherapyBritish Journal of Haematology, 1988
- Chromogranin A expression in normal and malignant human tissues.Journal of Clinical Investigation, 1988
- The value of bone marrow trephine biopsy in the diagnosis of metastatic neuroblastomaJournal of Pediatric Hematology/Oncology, 1985
- A Method of Detecting Neuroblastoma in Human Bone Marrow by Means of Two Monoclonal Antibodies PI 153/3 and KE2Hybridoma, 1985
- USE OF PANELS OF MONOCLONAL ANTIBODIES IN THE DIFFERENTIAL DIAGNOSIS OF NEUROBLASTOMA AND LYMPHOBLASTIC DISORDERSThe Lancet, 1983
- Neurone specific enolase: an aid to the diagnosis of melanoma and neuroblastomaHistopathology, 1982
- Hybrid Myelomas Producing Antibodies Against a Human Neuroblastoma Antigen Present on Fetal BrainScience, 1979